AoFrio has another strong quarter, Q2 revenue growth of 41%
AO132
22 July 2024
Market Announcement
For immediate release
AoFrio has another strong quarter, Q2 revenue growth of 41%
On 23 April 2024, AoFrio announced its trading result for the three months ended 31 March 2024 and stated
that it expected robust revenue growth in Q2-2024. This was achieved.
Revenue for Q2-2024 was $21.8m compared to $15.5m in Q2-2023, a 41% increase.
For the six months ended 30 June 2024 (H1-2024), revenue was $38.4m, a 27% increase over H1-2023.
EBITDA for H1-2024 was a profit of $1.1m, a $1.8m improvement over an EBITDA loss of $0.7m in the prior
comparable period.
AoFrio will release its Interim Report with a comprehensive commentary on the Company’s trading
performance and FY2024 outlook in August 2024.
*EBITDA (i.e., Earnings before interest, taxation, depreciation, amortisation, and impairment) is a non-GAAP
earnings figure that equity analysts tend to focus on for comparable company performance analysis. AoFrio
considers it a valuable financial indicator because it avoids the distortions caused by differences in
amortisation and impairment policies. Contact
Ends
Contact
Greg Balla Howard Milliner
Chief Executive Officer Chief Financial Officer
Phone + 64 21938601 +64 275870455
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFI — Australian Foundation Investment Company Limited: Preliminary Final Report2024-07-28
“Australian Foundation Investment Company Limited 1 Australian Foundation Investment Company Limited Results for Announcement to the Market The reporting period is the year ended 30 June 2024, with the prior corresponding period being the year ended 30 June 2023. Thi…”
- AFT — AFT Pharmaceuticals Limited: AFT reports record revenue and earnings2024-05-22
“AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 Results for announcement to the market AFT Pharmaceuticals Limited Reporting Period 12 months to 31 March 2024 Previo…”
- AFT — AFT Pharmaceuticals Limited: AFT to announce full year results on May 23 20242024-05-02
“3 May 2024 AFT Pharmaceuticals to announce full year results on Thursday May 23 2024 AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release its full year FY2024, ended March 31 2024, results on Thursday May 23 2024. The release will b…”